Leaderboards/Infective Endocarditis Diagnosis and Management

Infective Endocarditis Diagnosis and Management

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Geum‐Jae Jeong
Pukyong National University
2
Thomas W. van der Vaart
Utrecht University
3
Priyanka Bhugra
Houston Methodist
4
Jia‐Hong Tian
Nankai University
5
Nicolas Fourré
University of Lausanne
6
Chirag A. Buch
The University of Texas at San Antonio Health Science Center
7
Laure Flurin
Mayo Clinic in Arizona
8
Corina-Ioana Anton
Titu Maiorescu University
9
Sebastián Santos-Patarroyo
Brigham and Women's Hospital
10
Jinyong Chen
Second Affiliated Hospital of Zhejiang University

Papers

1
Bacterial extracellular vesicles: Modulation of biofilm and virulence properties
Acta Biomaterialia|2024
85 cit.
2
Enhancing aortic valve drug delivery with PAR2-targeting magnetic nano-cargoes for calcification alleviation
Nature Communications|2024
44 cit.
3
External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis
Clinical Infectious Diseases|2024
42 cit.
4
Publication in Clinical Infectious Diseases (2024) [20 citations, W4399392546]
Clinical Infectious Diseases|2024
20 cit.
5
Control of Staphylococcus aureus infection by biosurfactant derived from Bacillus rugosus HH2: Strain isolation, structural characterization, and mechanistic insights
Journal of Hazardous Materials|2024
19 cit.
6
Publication in Clinical Infectious Diseases (2024) [18 citations, W4393147403]
Clinical Infectious Diseases|2024
18 cit.
7
Publication in The Brazilian Journal of Infectious Diseases (2024) [11 citations, W4402683042]
The Brazilian Journal of Infectious Diseases|2024
11 cit.
8
Publication in Infection (2025) [7 citations, W4406990230]
Infection|2025
7 cit.
9
Publication in Microorganisms (2025) [6 citations, W4408292297]
Microorganisms|2025
6 cit.
10
Publication in Microorganisms (2024) [4 citations, W4396576423]
Microorganisms|2024
4 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Islamjan Sharipov
Interstate Commission for Water Coordination of Central Asia
2
Christopher Toly
American Heart Association
3
Jamol Uzokov
Tashkent Pediatric Medical Institute
4
Victor Aboyans
Institut d’Epidémiologie Neurologique et de Neurologie Tropicale
5
Mohamad Alkhouli
Mayo Clinic
6
Karen G. Zimmerman
West Virginia University
7
Buzz About
Unknown
8
Robby Markwart
Robert Koch Institute
9
Juan Carlos Segura Luque
Mútua Terrassa
10
Sudarshan Balla
West Virginia University

Papers

1
Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion
JACC. Clinical electrophysiology|2022
172 cit.
2
Transcatheter Edge-to-Edge Mitral Valve Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock
Journal of the American College of Cardiology|2022
82 cit.
3
Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry
European Heart Journal|2022
74 cit.
4
Left Atrial Appendage Occlusion
JACC Advances|2022
70 cit.
5
Infective endocarditis in adult patients with congenital heart disease
International Journal of Cardiology|2022
48 cit.
6
Predictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry
European Heart Journal|2023
41 cit.
7
Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition Examination Survey 2017–2020
European Journal of Preventive Cardiology|2022
30 cit.
8
Trends, Predictors, and Outcomes of 30‐Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database
Journal of the American Heart Association|2022
30 cit.
9
Trends in Infective Endocarditis Mortality in the United States: 1999 to 2020: A Cause for Alarm
Journal of the American Heart Association|2023
27 cit.
10
Temporal trends in atherosclerotic cardiovascular disease risk among U.S. adults. Analysis of the National Health and Nutrition Examination Survey, 1999–2018
European Journal of Preventive Cardiology|2022
23 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Volkmar Falk
ETH Zurich
2
José Luis Zamorano
Centro de Investigación en Red en Enfermedades Cardiovasculares
3
Stephen Brecker
St George's, University of London
4
Henry F. Chambers
San Francisco General Hospital
5
William C. Roberts
National Institutes of Health
6
Didier Raoult
Aix-Marseille Université
7
Michael J. Mack
Baylor Jack and Jane Hamilton Heart and Vascular Hospital
8
James M. Musser
Houston Methodist
9
David K. Warren
University of Nebraska Medical Center
10
Kathryn A. Taubert
Southwestern Medical Center

Papers

1
2017 ESC/EACTS Guidelines for the management of valvular heart disease
European Heart Journal|2017
6.3k cit.
2
2015 ESC Guidelines for the management of infective endocarditis
European Heart Journal|2015
5k cit.
3
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
International Journal of Antimicrobial Agents|2020
5k cit.
4
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
New England Journal of Medicine|2019
4.8k cit.
5
2014 ESC/EACTS Guidelines on myocardial revascularization
European Journal of Cardio-Thoracic Surgery|2014
4.2k cit.
6
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
Clinical Infectious Diseases|2011
4.2k cit.
7
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases|2009
3.6k cit.
8
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
New England Journal of Medicine|2018
2.9k cit.
9
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Circulation|2006
2.8k cit.
10
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
European Heart Journal|2016
2.5k cit.

Reagents for Infective Endocarditis Diagnosis and Management

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Bax Antibody

#2774$317
View Evidence →
Cell Signaling TechnologyEvidence 66

Phospho-BLNK (Thr152) (E4P2P) Rabbit Monoclonal Antibody

#62144$176,415
View Evidence →
Cell Signaling TechnologyEvidence 64

Neurofilament-H (E7Z7G) Rabbit Monoclonal Antibody (BSA and Azide Free)

#40459$865
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

PathScan® RP Total EGF Receptor Sandwich ELISA Kit

Cited in 5 papers
#80869$67,830,490
View Evidence →
Cell Signaling TechnologyEvidence 67

MGMT Antibody

#2739$317
View Evidence →
Cell Signaling TechnologyEvidence 66

SRC-3 (11B1) Mouse Monoclonal Antibody

#2115$158,348
View Evidence →